Skip to main content
BFNH
OTC Industrial Applications And Services

Controlling Shareholder Sells 80% Stake Amidst Going Concern Warning and Zero Revenue

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
10
Price
$0.55
Mkt Cap
$18.437M
52W Low
$0.163
52W High
$2.08
52W Position info
237% above low
Off High info
74% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

BFNH has more than doubled off its 52-week low of $0.163.

Summary

BIOFORCE NANOSCIENCES HOLDINGS, INC. reported continued zero revenue, a going concern warning, and material weaknesses, with its Chairman selling an 80% controlling stake post-quarter.


Key Events · Corporate Governance and Compliance · BFNH

  • Controlling Interest Sold

    Chairman Merle Ferguson sold his approximately 80% controlling stock interest in a private transaction to Nexus Capital Investments, Inc. on April 15, 2026. This represents a significant change in ownership and control.

  • Going Concern Warning

    The company continues to report recurring losses, net current liabilities, and an accumulated deficit, raising substantial doubt about its ability to continue as a going concern. Cash on hand is minimal at $6,347.

  • Zero Revenue & Increased Liabilities

    For Q1 2026, the company reported zero revenue and an increased total liabilities of $727,301, up from $619,329 at year-end 2025.

  • Material Weaknesses in Internal Controls

    Management identified material weaknesses in internal control over financial reporting, including inadequate segregation of duties and a lack of review in the financial reporting process.


Analysis · BFNH · Industrial Applications And Services

This quarterly report reveals a company in severe financial distress, marked by zero revenue, recurring losses, and a critical "going concern" warning. The most significant development is the post-quarter sale of an 80% controlling interest by Chairman Merle Ferguson to Nexus Capital Investments, Inc. This change of control, coupled with the company's precarious financial state and disclosed material weaknesses in internal controls, indicates a fundamental shift and raises serious questions about its future viability. While Ferguson also forgave accrued compensation, this is heavily overshadowed by the controlling stake sale.

At the time of this filing, BFNH was trading at $0.55 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $18.4M. The 52-week trading range was $0.16 to $2.08. This filing was assessed with negative market sentiment and an importance score of 10 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BFNH - Latest Insights

BFNH
Jul 01, 2026, 9:15 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.65
Real-time Price: $2.03 info
Change: +$0.380 (+23%) info
Market Cap: $68.104M info
BFNH
Jun 18, 2026, 8:28 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.78
Real-time Price: $2.03 info
Change: +$0.250 (+14%) info
Market Cap: $68.104M info
BFNH
May 19, 2026, 1:13 PM EDT
Filing Type: 10-Q
Importance Score:
10
Price at Filing: $0.550
Real-time Price: $2.03 info
Change: +$1.48 (+269%) info
Market Cap: $68.104M info
BFNH
Apr 15, 2026, 3:10 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.4536
Real-time Price: $2.03 info
Change: +$1.58 (+348%) info
Market Cap: $68.104M info